More on STOK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-92.5% Growth)
- Ratings (7.6 Score)

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Stoke Therapeutics Inc. (NQ:STOK)
Delayed: 29.05 -0.06 (0.21%)
Prev. Close $29.11  
Open$28.83 
52 Wk High$ 
52 Wk Low$ 
Day High$29.49 
Day Low$28.48 
P/E N/A  
EPS$ 
Volume413,964 

Friends, Peers and Foes (?): BIIB, VRTX, ZEAL, ANVS, ARQT (more...)

Jul 17, 2026 04:37 PM Form 4 Stoke Therapeutics, Inc. For: Jul 16 Filed by: Harrison Seth Loring
Jul 17, 2026 04:36 PM Form 4 Stoke Therapeutics, Inc. For: Jul 15 Filed by: McCauley Thomas
Jul 17, 2026 04:33 PM Form 3 Stoke Therapeutics, Inc. For: Jul 13 Filed by: McCauley Thomas
Jul 16, 2026 04:01 PM Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jul 13, 2026 07:30 AM Stoke Therapeutics names Thomas McCauley as chief scientific officer
Jul 13, 2026 07:30 AM Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
Jul 13, 2026 05:10 AM Goldman Sachs Starts Stoke Therapeutics (STOK) at Buy
Jul 6, 2026 04:11 PM Form 4 Stoke Therapeutics, Inc. For: Jul 01 Filed by: Ticho Barry
Jul 1, 2026 04:52 PM Form 144 Stoke Therapeutics, Inc. Filed by: Ticho Barry
Jun 30, 2026 08:02 AM Form 8-K Stoke Therapeutics, Inc. For: Jun 30
View All Articles

Entities mentioned with STOK

View All Entities